skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: In vitro and in vivo properties of (/sup 125/I) (R,S) 4IQNB: A lower affinity diastereomeric muscarinic receptor radiotracer

Conference · · J. Nucl. Med.; (United States)
OSTI ID:6651845

The (R,R) diastereomer of 3-Quinuclidinyl 4-Iodobenzilate (4IQNB) is a high affinity muscarinic acetylcholine receptor radiotracer which has provided images of receptor distribution in the CNS of man. The radiotracer is of such high affinity that dissociation in vivo is not evident in man after 6-half-lives I-123. Since the dissociation kinetics of radiotracer may be helpful for receptor quantitation, the authors have prepared (/sup 125/I) (R,S) 4IQNB: a diastereomer of 4IQNB which as a lower affinity for the m-AChR than the (R,R) isomer. The equilibrium association constant for the (R,S) diastereomer is 1.10 x 10/sup 9/ M/sup -1/, which is 4-fold lower in affinity than (/sup 3/H) (R) QNB and 2-fold lower than that of the (R,R) 4IQNB. Of more interest, the dissociation rate constant of (R,S) 4IQNB is 0.099 (+0.01)/min., 15-fold more rapid than that of the (R,R) isomer. The systemic distribution of (R,S) 4IQNB is similar to that of (R,R) 4IQNB except localization in the myocardium is 2-fold lower, reflecting the lower affinity. Nonreceptor interactions are the same since the compounds differ only as optical isomers around the carbinol chiral center. In the CNS peak activities are obtained in the corpus striatum (and other M/sub 1/-receptor rich structures) which are the same as obtained with (R,R) 4IQNB. However, no washout of (R,R) 4IQNB is observed after 4 hrs and only 60% in 24 hrs. By contrast, 65% of (R,S) 4IQNB washes out in 4 hrs and no significant activity is detected after 24 hrs. The increased washout kinetics should provide a better radiotracer for determining muscarinic receptor concentrations in the CNS of man.

Research Organization:
The George Washington Univ. Medical Center, Washington, DC
OSTI ID:
6651845
Report Number(s):
CONF-850611-; TRN: 87-015115
Journal Information:
J. Nucl. Med.; (United States), Vol. 26:5; Conference: 32. annual meeting of the Society of Nuclear Medicine, Houston, TX, USA, 2 Jun 1985
Country of Publication:
United States
Language:
English